Abstract. Increasing studies suggest that autophagy has a protective role in cancer treatment and may even be involved in chemotherapy resistance. Nevertheless, the mechanism of autophagy in cancer treatment and drug resistance has not yet been established. There is a complex association between autophagy and apoptosis. Accordingly, these two processes can mutually regulate and transform to determine the fate of a cell, depending on the context. Activating molecule in Beclin 1-regulated autophagy protein 1 (Ambra1) is an important factor at the crossroad between autophagy and apoptosis. The expression level and intracellular distributions of Ambra1 may control the balance and conversion between autophagy and apoptosis, and modify the effectiveness of chemotherapy. Therefore, Ambra1 may provide a novel target for cancer treatment, particularly for overcoming anticancer drug resistance. The present review focuses on the role of Ambra1 in autophagy and apoptosis and assesses the implications for cell survival and chemotherapy resistance.
Contents1. Introduction 2. Autophagy process and its dual role in cell death and survival 3. Autophagy in cancer therapeutic responsiveness and chemotherapy resistance 4. Ambra1 is a positive factor of autophagy 5. Ambra1 is a negative factor of apoptosis execution 6. Ambra1 in cell survival and implications for chemotherapy resistance 7. Conclusion
IntroductionMacroautophagy, which is also referred to as autophagy, is a protein degradation process in eukaryotic cells. The role of autophagy in cancer treatment has been extensively studied, yet the results remain controversial. Although certain studies indicate that autophagy participates in chemotherapy resistance, the mechanism is not yet clear (1). A recent series of studies suggest that activating molecule in Beclin 1-regulated autophagy protein 1 (Ambra1) is an important factor in regards to the association between autophagy and apoptosis, and may control the reciprocal conversion between the two processes to decide the resulting cell death or survival (2-4). Therefore, Ambra1 may be an important factor of autophagy involved in cancer treatment and chemotherapy resistance. The present review focuses on the role of Ambra1 in autophagy and apoptosis and assesses the implications for cell survival and chemotherapy resistance.
Autophagy process and its dual role in cell death and survivalAutophagy is an evolutionarily conserved lysosome-dependent cellular catabolic degradation process in eukaryotic cells (5). In general, basal autophagy exists in cells to maintain cellular homeostasis through the degradation of long-lived proteins, protein aggregates and damaged organelles. However, autophagy is rapidly upregulated under adverse conditions, including nutrient deprivation, hypoxia, radiation and anticancer drugs, to recycle energy and supply macromolecules for biosynthesis, leading to the cells adapting to the stress and survival (5-13). Three major types of autophagy have been reported, including macroautophagy, microautophagy and ...